As of 2024-12-13, the Intrinsic Value of Rocket Pharmaceuticals Inc (RCKT) is
-14.16 USD. This RCKT valuation is based on the model Peter Lynch Fair Value.
With the current market price of 12.57 USD, the upside of Rocket Pharmaceuticals Inc is
-212.61%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-14.16 USD
Intrinsic Value
RCKT Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-14.16 - -14.16 |
-14.16 |
-212.61% |
| P/E |
(31.93) - (54.13) |
(51.38) |
-508.8% |
| DDM - Stable |
(40.40) - (665.26) |
(352.83) |
-2906.9% |
| DDM - Multi |
(36.86) - (474.00) |
(68.52) |
-645.1% |
RCKT Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,145.88 |
| Beta |
1.54 |
| Outstanding shares (mil) |
91.16 |
| Enterprise Value (mil) |
1,101.51 |
| Market risk premium |
4.60% |
| Cost of Equity |
6.64% |
| Cost of Debt |
5.00% |
| WACC |
6.60% |